What does this video actually claim?
This TikTok from @britishciggies shows someone celebrating what appears to be a milestone in their hormone replacement therapy journey. The creator uses hashtags like #transfem and #hrt while expressing excitement about their "best day ever."
The video doesn't make explicit medical claims, but it's tagged under testosterone replacement therapy despite the #transfem hashtag suggesting feminizing hormones. This creates confusion about what treatment they're actually discussing.
The celebratory tone implies positive outcomes from hormone therapy, but without specific details about dosages, timeline, or effects experienced.
What's missing from this celebration?
Hormone therapy for gender-affirming care involves serious medical considerations that this upbeat video glosses over. The Coleman et al. Standards of Care (2022) emphasize thorough evaluation and informed consent before starting any hormone regimen.
For transfeminine individuals, estradiol therapy typically starts at 1-2mg daily with spironolactone 50-100mg daily as an anti-androgen. The WPATH guidelines note that effects like breast development and fat redistribution can take 2-5 years to fully manifest.
Mental health outcomes do improve for many people. The Bauer et al. study (2015) found reduced psychological distress in transgender individuals accessing hormone therapy, but this required proper medical supervision and realistic expectations.
Why does the category mismatch matter?
This video is incorrectly categorized under testosterone replacement therapy when the #transfem hashtag indicates feminizing treatment. This isn't just a tagging error, it reflects broader confusion about transgender healthcare.
Testosterone therapy for cisgender men typically involves doses of 150-200mg weekly of testosterone cypionate or enanthate. That's completely different from transfeminine hormone regimens that suppress testosterone while adding estrogen.
The Hembree et al. Endocrine Society guidelines (2017) stress that these are distinct treatment protocols with different monitoring requirements, risks, and expected outcomes.
What should people actually know about HRT?
Gender-affirming hormone therapy can be life-changing, but it requires medical oversight and realistic timelines. The excitement shown here is understandable, but viewers need facts, not just celebration.
Blood work monitoring is essential every 3-6 months initially. Estradiol levels should reach 100-200 pg/mL, while testosterone drops below 50 ng/dL in transfeminine patients. These aren't suggestions, they're medical necessities.
The T'Sjoen et al. European consensus (2019) found that properly managed hormone therapy has acceptable safety profiles, but emphasized the need for individualized treatment plans rather than one-size-fits-all approaches.